Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) EBITDA (2016 - 2025)

Historic EBITDA for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $78.7 million.

  • Healthequity's EBITDA rose 127988.78% to $78.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $248.6 million, marking a year-over-year increase of 15706.5%. This contributed to the annual value of $96.7 million for FY2025, which is 7357.66% up from last year.
  • As of Q4 2025, Healthequity's EBITDA stood at $78.7 million, which was up 127988.78% from $89.6 million recorded in Q3 2025.
  • Over the past 5 years, Healthequity's EBITDA peaked at $89.6 million during Q3 2025, and registered a low of -$32.8 million during Q1 2022.
  • In the last 5 years, Healthequity's EBITDA had a median value of $5.5 million in 2021 and averaged $15.5 million.
  • In the last 5 years, Healthequity's EBITDA crashed by 247972.97% in 2021 and then soared by 1271435.41% in 2024.
  • Healthequity's EBITDA (Quarter) stood at -$5.0 million in 2021, then soared by 67.43% to -$1.6 million in 2022, then surged by 994.15% to $14.7 million in 2023, then plummeted by 61.13% to $5.7 million in 2024, then soared by 1279.89% to $78.7 million in 2025.
  • Its last three reported values are $78.7 million in Q4 2025, $89.6 million for Q3 2025, and $53.9 million during Q2 2025.